Reacting to epidemic and emerging infectious diseases: QIAGEN's diagnostic and surveillance response to MPXV
MonkeyPox is a zoonotic disease that can be fatal. The disease is considered endemic in west and central Africa, but cases are infrequent. There has been a recent public health concern as MonkeyPox cases have seen a resurgence in non-endemic countries across the globe, including in Europe, North America, and Australia.
This webinar will provide an epidemiological and clinical overview of the current MonkeyPox outbreak in non-endemic regions. Diagnostic challenges and QIAGEN’s RUO solutions will also be discussed.
Key learning objectives
- Update on MonkeyPox epidemiology and disease overview
- Diagnostic challenges of MonkeyPox
- QIAGEN’s molecular solutions for research and surveillance
Who should attend?
- Clinical virologists
- Medical technologists
- Infectious disease physicians
- Public and Global health specialists
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Clinical Content Editor, SelectScience
Chief Medical Officer, QIAGEN</p>